Cue Biopharma, Inc.CUENASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank30
Studio
Year-over-Year Change

Return on invested capital

Latest
-86.69%
↓ 14% vs avg
Percentile
P30
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-75.90%
Historical baseline
PeriodValueYoY Change
2025-86.69%+44.9%
2024-157.35%-56.2%
2023-100.71%-60.8%
2022-62.62%-11.0%
2021-56.39%-10.2%
2020-51.19%+10.4%
2019-57.10%+42.2%
2018-98.85%-162.1%
2017-37.71%+25.1%
2016-50.35%-